Identifying disease genes from a vast amount of genetic data is one of the most challenging 22 tasks in the post-genomic era. Also, complex diseases present highly heterogeneous 23 genotype, which difficult biological marker identification. Machine learning methods are 24 50 Complex diseases with a strong genetic influence, such as Autism Spectrum Disorder 51 (ASD), often have multiple etiologies with the involvement of possibly hundreds of 52 different genes. Recent advances in genetic technologies have led to more efficient 53 acquisition of genetic data. For example, the many large-scale genetic studies for ASD have 54 identified hundreds of candidate disease (1,2). However, given the vast amount of data 55 generated by these large-scale studies, identifying true disease genes has become a daunting 56 task. For example, a genetic etiology is identified for only 20 to 25% of ASD cases (3), 57 thus demanding more efforts to unravel ASD causing genes.
Introduction based SVM to predict disease genes. Linear and radial SVM was applied using e1071 140 (version 1.6.8) R package (19) . Equal class weights were defined for both positive and 141 negative classes. 1 and 0.001 values were used for cost and epsilon parameters respectively.
142
For radial-SVM gamma was set to 0.02.
143
NB is a simple probabilistic classifier based on the Bayes' theorem with the assumption of 144 strong (naive) independence between every pair of predictors. This simplest Bayesian 145 classifier can be trained efficiently and performs well in practice, even when the 146 assumption of features independence is not valid. It was trained as a conditional probability 147 model, where conditional probability distribution of each observation is estimated using 148 Bayes' theorem and then uses it for the prediction of class labels for test set instances. NB 149 was applied using e1071 R package. NB was used without Laplace smoothing.
150
Evaluation of the classifiers 151 All classifiers were evaluated using two different assessment approaches, namely stratified 152 five-fold cross-validation and held-out restricted stratified five-fold cross-validation, 3) Test the trained classifier using the remaining fold (test set). 159 4) Repeat the process five times and each time a different fold is used as a test set ( Fig   160   3 ).
161
In held-out restricted stratified five-fold cross-validation, the classifier is tested using a 162 subset of test set (step 3), named as held-out (Fig 3) . 163 Similar to Krishnan et al.'s method, the Area Under receiver-operator Curve (AUC) 164 evaluation metric was used to estimate and compare the performance of all generated 165 classifiers. To avoid bias from self-similarity scores, during cross-validation, the semantic 166 similarity squared matrix was split into five folds. So, genes selected to be as instances in 167 the test set were removed as features from the test and training set. This avoided the usage 168 of self-similarity values in the test set. For example, for a given set of five genes: g1...g5, 169 the semantic similarity matrix is of 5x5 dimensions. If g1...g3 are used as instances in the 170 training set then g4 and g5 are in the test set so they cannot be used as features in the 171 training set. The training set matrix is therefore reduced to 3x3 dimensions with the three IC-based methods compute a semantic score between two GO terms using the IC of their 196 Most Informative Common Ancestor (MICA) term. Wang measure uses the hierarchical 197 structure of the GO to calculate the semantic similarity scores between the given terms.
198
The Max strategy of combining semantic similarity scores across all GO terms associated 199 with given genes was used. Let g1 and g2 are two different genes annotated with following 200 list of GO terms ( 11, 12 … … 1 ) and ( 21, 22 … … 2 ), respectively. The max combining 201 criteria compute the maximum semantic similarity score over all possible pairs of terms 202 between the two term lists as follows:
203
( 1 , 2 ) = 1≤ ≤ ,1≤ ≤ ∼ ( 1 , 2 ) (2) 204 GO terms with electronic evidence code (IEA) were dropped during semantic similarity 205 score calculation. GO information for both ASD and non-mental genes were obtained from 206 org.Hs.eg.db R package (23). Only terms from the biological process aspect were used to 207 assess functional similarities between the genes. All semantic similarity measures were 208 implemented using GOSemSim (version 2.0.4) R package (24). To guarantee that the 209 results are independent of the measure, we decided not to use our in-house developed 210 DiShIn tool and measure (25), but we expect to get similar or better performance with more 211 refined measures. There are more than 40 thousand GO terms representing biological concepts. However, 213 some genes still lack GO information and result in missing semantic scores. Genes with 214 missing similarity scores were excluded at the beginning of the analysis. We did not assign 215 0 values to missing scores, to avoid confusion because there were with the genes in dataset 216 that really had a semantic similarity of 0. Therefore, replacing missing scores with 0 can 217 induce bias in predictions and also could result in a bias estimation of classifier 218 performance. All disease gene prediction approaches largely depend upon data and each 219 dataset has its own limitations. For example, protein-protein interaction networks have the 220 limitation of not considering weakly interacting proteins, as these are difficult to ascertain 221 experimentally. Similarly, the presented approach is also dependent upon gene semantic 222 similarities scores, which were unavailable for a few genes. However, in our dataset, To make the designed methodology accessible to researchers lacking extensive machine 229 learning and programming knowledge, we developed an easy to use workflow. The 230 workflow was developed using the KNIME framework (https://www.knime.com/). KNIME
231
is an open source framework implementing several machine learning algorithms and data 232 analysis utilities. The developed automated KNIME workflow incorporates all the above-233 discussed machine learning and semantic similarity measures to predict disease genes.
234
Case study dataset 235 To implement the proposed methodology, genes with evidence for an involvement in ASD 236 were obtained from the Simons Foundation Autism Research Initiative (SFARI) gene 237 database (N = 990) (https://gene.sfari.org/), accessed on March 2018. The SFARI gene 238 database is a catalogue of ASD relevant genes that have been reported by previous studies.
239
In the SFARI database, genes are scored into seven different categories with respect to the 240 strength of the available evidence. Genes with strongest and reproducible evidence are 241 assigned to category 1 and genes with certain reproducibility limitations are placed in 242 10 category 2. Category 3 and 4 contains genes with evidence from small studies of ASD 243 candidate genes, while genes belonging to category 5 have indirect evidence of association.
244
Category 6 genes are not associated with ASD. The SFARI gene database also contains 245 syndromic genes that cause genetic pathologies presenting with ASD symptoms.
246
Syndromic genes are placed in a separate syndromic category. Genes from category 1, 2, 3 247 and 4 (N = 588) were selected for the analysis. All genes classified as syndromic but are 248 not in these categories were excluded. Besides ASD association, syndromic genes are also 249 associated with diverse phenotypes and may disrupt biological processes unrelated to ASD. First, classifiers were trained and tested on HD and non-mental genes and were evaluated 281 using stratified five-fold cross-validation. There were less HD ASD genes than non-mental 282 genes. Therefore, to control class imbalance, the majority class (non-mental genes) was 283 undersampled. Secondly, functional similarities of HD + LD and non-mental genes were 284 calculated to design various classifiers. The performance of these classifiers was assessed 285 using two different assessment approaches, namely stratified five-fold cross-validation and 286 held-out restricted five-fold cross-validation.
287
Predicting new ASD genes using the semantic similarity based classifier 288 Copy Number Variants (CNVs) are common genetic risk factors for many diseases, 289 including ASD. Specially, de novo CNVs play an important role in ASD pathogenesis and 290 occur at higher rates in patients than in their siblings or controls (26). Mostly, de novo 291 CNVs (present in patients but not in their parents) frequently disrupt many genes, posing 292 challenges for the identification of the disease among the many disrupted genes.
293
ASD candidate gene predictions were made to further estimate the predictability of the built 294 classifier. For this purpose, genes disrupted by rare de novo CNVs (N = 80) in ASD 295 patients were obtained from Sander et al. (27) . We used our generated classifier to predict 296 ASD genes from genes spanned by rare de novo CNVs in subjects that were diagnosed with 297 ASD. Genes overlapping with training set and lacking GO annotations were excluded from 298 analysis.
299

Results
300
In this study, we evaluated the performance of machine learning methods in predicting the 301 ASD candidate genes. For this purpose, functional similarities of ASD genes along with 302 non-mental genes were calculated by applying semantic similarity measures. Table 1 shows 303 13 the performance of different machine learning classifiers constructed over functional 304 similarities scores, determined by using three different semantic similarity measures. 305 Resnik, Wang, and Rel measures were used to calculate functional similarities for HD ASD 306 and non-mental genes. Four different machine learning methods (RF, NB, linear-SVM, and 307 radial-SVM) were trained on each semantic similarity matrix, resulting in total of twelve 308 different classifiers for HD genes. Out of these classifiers, RF-based classifiers trained and 309 tested on all semantic similarity matrices outperformed the other classifiers (Table 1) . Table   310 1: The performance of classifiers trained and tested over different semantic similarities 311 matrices and validated using stratified and held-out restricted stratified validation. The classify HD ASD genes. The stratified five-fold cross-validation approach was used to 320 evaluate all the classifiers of HD and non-mental genes.
321
Classifiers were also built using functional similarities of HD + LD and non-mental genes 322 and were evaluated by stratified five-fold cross-validation. The performance of classifiers 323 for each semantic similarity matrix of HD + LD genes and non-mental genes was lower 324 than the HD genes based classifiers, except for linear, and radial SVM (Table 1) (Table 1) .
330
A held-out restricted validation approach was adapted from Krishnan et al. to assess the 331 performance of the proposed classification approach. For this purpose, classifiers were built 332 using functional similarities of HD + LD genes and non-mental genes. However, during 333 stratified five-fold cross-validation, evaluation was done using only HD ASD and non-334 mental genes.
335
For each semantic similarity matrix, held-out restricted RF classifier outperformed HD and 336 HD+LD classifiers (evaluated using stratified five-fold cross-validation). In parallel with 337 previously built classifiers (HD and HD+LD), the performance of held-out restricted 338 classifiers for all semantic similarity measures was comparable (Table 1) . Despite the 339 improved performance than HD and HD+LD classifiers, held-out restricted linear and 340 radial SVM failed to classify ASD genes (Table 1) . NB classifiers that were evaluated only 341 on HD genes also obtained better performance over other classifiers, evaluated without any 342 restriction. However, improved performance of NB classifiers was only observed for Wang 343 and Rel semantic scores (Table 1) .
344
The reported semantic similar matrices, Resnik, Rel and Wang were calculated using the 345 Max combining criteria. Semantic similar matrices were also calculated by the Boot Mean 346 Average (BMA) combining criteria. However, classifiers constructed using genes semantic 347 15 scores with the BMA combining criteria showed lower performance than classifiers built on 348 semantic scores of Max combining criteria (S1 Table ) . 349 We also have developed a KNIME workflow of the designed methodology. The implements the steps 2 and 3 of proposed methodology (Fig 1) .
363
It can be extended according to the specific objective such as adding another class of 364 disease genes. This workflow also incorporates R nodes to calculate functional similarity 365 between genes, thus allowing programming experts to add any new method by modifying 366 the corresponding R node. Moreover, the model generated using automated workflow can 367 be saved on the local computer and can also be easily invoked to make predictions for new 368 datasets.
369
To predict novel ASD candidate genes from genes disrupted by de novo CNVs in patients, 370 we used our best classifier, namely the RF classifier trained and tested on Resnik semantic 371 similarity matrix, calculated using HD and non-mental genes. This RF-Resnik classifier 372 was also evaluated by tuning its parameters, such as number of trees. RF classifier showed 373 the highest performance when the number of trees was set to 500 (S2 Table) . The classifier 374 predicted 73 ASD genes out of 554 genes that were disrupted by denovo CNVs in ASD 375 patients. The Enrichr (28) tool was employed to find enriched biological pathways and 376 Human Phenotype Ontology (HPO) terms for predicted genes. 99 HPO terms were found 377 significantly enriched for 73 predicted genes (Table 2 and S3 Table) . The top 2 most significantly enriched HPO terms were Vesicoureteral reflux and Autism. 381 However, only the histone modifications pathway was marginally significantly enriched for 382 predicted genes (adjusted p = 0.065 at α < 0.05). objective was to study which approach is more suitable.
378
400
The HD ASD genes based classifier also outperformed the RF classifiers using the clinical phenotype. The classifier tested on only HD ASD genes may lack robustness for 410 genes that are responsible for a milder expression of ASD or for comorbidities, thus 411 limiting the coverage of the predictive classifier.
412
The strength of the reported semantic similarity scores is its independence from the features 413 (genes) weighting scheme, defined by the ranking of genes according to available evidence.
414
The standard criteria for ranking ASD genes by available reference is not yet completely 415 defined (29), and, therefore, it is possible that incorporating weighting criteria for genes 416 could introduce a bias. In the present study, we used semantic similarity scores of genes, 417 which range from 0 to 1, with semantic similarity scores closer to 1 indicating high 418 functional similarity between genes. If the gene is not directly involved in ASD then the 419 target gene will show less similarity with disease-causing genes, hence lowering its 420 contribution in classification. For this reason, we did not apply any weighting criteria. This 421 automates the process and allows increasing performance as GO evolves.
422
The improved performance of the classifier with semantic similarities further confirmed the annotations are less dependent on context. Additionally, our study further confirmed that 428 machine learning methods can be used to predict disease genes and their performance can 429 be improved by adding more data with different domain information.
430
One limitation of this approach is the full dependence on the available annotation resources.
431
Genes lacking GO annotations are filtered in the analysis. But this may improve in future 432 because the number of GO terms and annotations are continuously increasing with time. 433 We also provided a downloadable and easy to use workflow of the designed methodology.
434
The designed workflow permits the user to test more than one machine learning and developed workflow includes all necessary tools for disease gene prediction and provides 439 an opportunity for researchers to analyze their own private data without uploading it to 440 external websites, thus preventing any privacy issues.
441
Enrichment analysis revealed the enrichment of ASD predicted genes in histone 442 modification pathway. This was consistent with previously published studies, reporting 443 histone genes involvement in ASD (30). Only one pathway was significantly enriched for 444 ASD predicted genes. This might be because of a small number of input ASD genes.
445
Prediction with larger number of genes might produce more statistically significant 446 pathways.
447
ASD core symptoms are defined by deficits in social interaction and communication, and 448 repetitive behavior. However, these core symptoms manifest with a wide range of 449 phenotype, indicating ASD phenotypic heterogeneity. Functional enrichment analysis of 450 ASD genes, predicted by the RF classifier also showed a wide range of phenotypes. ASD 451 predicted genes were enriched in Autism and obsessive-compulsive behavior phenotypes, 452 further confirming the feasibility of the classifier in predicting new ASD genes. In addition,
453
five genes were also associated with the attention deficit hyperactivity disorder HPO term.
454
Attention deficit hyperactivity is one of most the common ASD comorbidity. A large 455 percentage of ASD children also develop attention deficit hyperactivity disorder symptoms 456 (31).
457
Although Random Forest (RF) performed better than other methods, its performance was 458 comparable with Naive Bayes (NB) algorithm. Therefore, we do not expect that RF will 459 achieve the best performance for other complex disease genes as well. The Support Vector 460 Machines (SVMs), both linear and nonlinear failed to make reasonable predictions, 461 probably, they are sensitive to number of features and number of records. Also, SVMs 462 perform preprocessing of data, which may not be feasible for this dataset.
463
In this study, we reported that gene functional similarities, assessed using GO annotations 464 can be used to identify new ASD genes. The classifier trained and tested using HD ASD 465 genes outperformed all others and previously reported classifiers. The objective of this 466 work was not to find the best semantic similarity measure for calculating functional 467 20 similarities of genes. However, the performance of the classifier can be further improved by 468 including more refined semantic similarity methods. Additionally, text mining techniques 469 may also be employed to find the functionality of genes in literature that are lacking 470 semantic scores (32). Moreover, to attain reliable ASD genes predictions, future studies 471 should be focused on combining protein-protein interactions with semantic similarity 472 scores. Additionally, integration of information such as gene expression and pathways data 473 with semantic scores can further improve the power of prediction.
474
In summary, we validated our hypothesis and have shown that the performance of available 475 state of the art methods for complex disease gene prediction can be improved by using only 476 GO annotations. One novel aspect of presented manuscript was the comparison of stratified 
